Skip to main content
. 2024 May 5;12(5):500. doi: 10.3390/vaccines12050500

Figure A29.

Figure A29

Sensitivity analysis, acute respiratory illness associated with respiratory syncytial virus infection in follow-up studies [48,61,85].